Recombinant Human IKZF1 Protein ，Avi & His

IKZF1, also known as Ikaros, is a key transcription factor that plays a critical role in hematopoiesis and the development of the immune system. Abnormalities in the IKZF1 gene, such as deletions or mutations, have been associated with various hematological malignancies, particularly in acute lymphoblastic leukemia (ALL). Research into IKZF1 has revealed its essential function in regulating the differentiation and proliferation of B and T lymphocytes, and it acts as a tumor suppressor in hematopoietic cells. Recombination of IKZF1 protein has become a focal point in understanding its structure-function relationships and the mechanisms by which it contributes to leukemogenesis. By generating recombinant IKZF1 proteins, researchers can investigate the impact of specific mutations on its activity, identify potential binding partners, and elucidate the pathways in which it is involved. This research is pivotal not only for understanding the pathophysiology of related malignancies but also for developing targeted therapies that can harness the functions of IKZF1 to improve therapeutic outcomes in patients with IKZF1-associated diseases. Through these studies, scientists aim to uncover novel insights into the regulatory networks governing immune cell development and function, ultimately leading to advances in cancer treatment and immunotherapy strategies.